Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Ross

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Experimental Medicine|December 1, 1980
Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulinJ D Lambris, N J Dobson, G D Ross
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1978
Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3E M Rabellino, G D Ross, M J Polley
Complement (Basel, Switzerland)|January 1, 1987
Role of complement receptor type three and serum opsonins in the neutrophil response to yeastJ A Cain, S L Newman, G D Ross
Clinical and Experimental Immunology|February 5, 1999
Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I moleculesV Vĕtvicka, M Hanikýrová, J Vĕtvicková, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1981
Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibodyJ D Lambris, N J Dobson, G D Ross
Clinical and Experimental Immunology|December 9, 1998
A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18)R K Reddy, Y Xia, M Hanikýrová, et al.
European Journal of Cell Biology|February 1, 1991
Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosisK B Pryzwansky, T Wyatt, W Reed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3V Vĕtvicka, W Reed, M L Hoover, et al.
Immunopharmacology|July 17, 1999
Therapeutic intervention with complement and beta-glucan in cancerG D Ross, V Vetvicka, J Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1997
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18)V Vetvicka, B P Thornton, T J Wieman, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Experimental Medicine|December 1, 1980
Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulinJ D Lambris, N J Dobson, G D Ross
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1978
Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3E M Rabellino, G D Ross, M J Polley
Complement (Basel, Switzerland)|January 1, 1987
Role of complement receptor type three and serum opsonins in the neutrophil response to yeastJ A Cain, S L Newman, G D Ross
Clinical and Experimental Immunology|February 5, 1999
Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I moleculesV Vĕtvicka, M Hanikýrová, J Vĕtvicková, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1981
Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibodyJ D Lambris, N J Dobson, G D Ross
Clinical and Experimental Immunology|December 9, 1998
A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18)R K Reddy, Y Xia, M Hanikýrová, et al.
European Journal of Cell Biology|February 1, 1991
Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosisK B Pryzwansky, T Wyatt, W Reed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3V Vĕtvicka, W Reed, M L Hoover, et al.
Immunopharmacology|July 17, 1999
Therapeutic intervention with complement and beta-glucan in cancerG D Ross, V Vetvicka, J Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1997
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18)V Vetvicka, B P Thornton, T J Wieman, et al.
Pageof 8